Showing results (1541-1550 of 1,580) with videos related to
Sort By:
Pageof 158
Contact in Context|January 8, 2024
Assessment of Vecuronium Quality Using Near-Infrared SpectrometryJames T Isaacs, Philip J Almeter, Aaron N Hunter, et al.Contact in Context|August 25, 2025
Potential Process Control Issues With AbataceptJames T Isaacs, Philip J Almeter, Aaron N Hunter, et al.Molecular Cancer Therapeutics|September 5, 2025
Anti-tumor activity of trastuzumab deruxtecan in pediatric solid tumors with variable HER2 expressionChelsey M Burke, Tamar Y Feinberg, Samantha Brosius, et al.Plant, Cell & Environment|October 6, 2022
A cross-scale analysis to understand and quantify the effects of photosynthetic enhancement on crop growth and yield across environmentsAlex Wu, Jason Brider, Florian A Busch, et al.Journal of Medicinal Chemistry|August 19, 2007
Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitorsMichele H Potashman, James Bready, Angela Coxon, et al.Contact in Context|May 22, 2024
Application of Near-Infrared Spectroscopy for Screening of Chlorothiazide Sodium VialsJames T Isaacs, Philip J Almeter, Aaron N Hunter, et al.Contact in Context|December 23, 2024
Potential Process Control Issues with VasopressinJames T Isaacs, Philip J Almeter, Aaron N Hunter, et al.Nature Communications|April 21, 2026
Habitual coffee intake shapes the gut microbiome and modifies host physiology and cognitionSerena Boscaini, Thomaz F S Bastiaanssen, Gerard M Moloney, et al.Journal of Medicinal Chemistry|March 4, 2008
Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesisDaniel S La, Julie Belzile, James V Bready, et al.Journal of Medicinal Chemistry|January 27, 2007
Alkynylpyrimidine amide derivatives as potent, selective, and orally active inhibitors of Tie-2 kinaseVictor J Cee, Brian K Albrecht, Stephanie Geuns-Meyer, et al.Pageof 158